Experience of an information aid for newly diagnosed multiple sclerosis patients: a qualitative study on the SIMS-Trial

Standard

Experience of an information aid for newly diagnosed multiple sclerosis patients: a qualitative study on the SIMS-Trial. / Borreani, Claudia; Giordano, Andrea; Falautano, Monica; Lugaresi, Alessandra; Martinelli, Vittorio; Granella, Franco; Tortorella, Carla; Plasmati, Imma; Radaelli, Marta; Farina, Deborah; Dalla Bella, Eleonora; Bianchi, Elisabetta; Acquarone, Nicola; Miccinesi, Guido; Solari, Alessandra; SIMS-Trial group ; Heesen, Christoph.

in: HEALTH EXPECT, Jahrgang 17, Nr. 1, 01.02.2014, S. 36-48.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

Borreani, C, Giordano, A, Falautano, M, Lugaresi, A, Martinelli, V, Granella, F, Tortorella, C, Plasmati, I, Radaelli, M, Farina, D, Dalla Bella, E, Bianchi, E, Acquarone, N, Miccinesi, G, Solari, A, SIMS-Trial group & Heesen, C 2014, 'Experience of an information aid for newly diagnosed multiple sclerosis patients: a qualitative study on the SIMS-Trial', HEALTH EXPECT, Jg. 17, Nr. 1, S. 36-48. https://doi.org/10.1111/j.1369-7625.2011.00736.x

APA

Borreani, C., Giordano, A., Falautano, M., Lugaresi, A., Martinelli, V., Granella, F., Tortorella, C., Plasmati, I., Radaelli, M., Farina, D., Dalla Bella, E., Bianchi, E., Acquarone, N., Miccinesi, G., Solari, A., SIMS-Trial group, & Heesen, C. (2014). Experience of an information aid for newly diagnosed multiple sclerosis patients: a qualitative study on the SIMS-Trial. HEALTH EXPECT, 17(1), 36-48. https://doi.org/10.1111/j.1369-7625.2011.00736.x

Vancouver

Bibtex

@article{6fff7bd7f13a426a809f1804b4568226,
title = "Experience of an information aid for newly diagnosed multiple sclerosis patients: a qualitative study on the SIMS-Trial",
abstract = "BACKGROUND: The SIMS-Trial (ISRCTN81072971) proved the effectiveness, in terms of patient's knowledge and care satisfaction, of an add-on information aid (personal interview with a physician using a navigable CD and take-home booklet) in 120 newly diagnosed patients with multiple sclerosis (MS) from five Italian centres.OBJECTIVE: To scrutinize the experience of SIMS-Trial participants in order to gain better understanding of the effectiveness of the information aid and its components.DESIGN: We performed (i) nine individual semi-structured interviews with a purposeful sample of SIMS-Trial patients who received the information aid, (ii) focus group meeting (FGM) with the physicians who conducted the personal interview, and (iii) FGM with patients' caring neurologists.RESULTS: Patients' experience with the information aid was positive as it enhanced their understanding of their disease, being viewed as a guided tour of their medical condition. The physicians who conducted the personal interviews were also positive in their overall evaluation but noted an initial difficulty in using the CD. The caring neurologists had limited direct experience of the aid, and their views were confined to utility of the information aid in general. All participants considered the combination of personal interview, CD navigation and take-home booklet essential, but urged a more flexible scheduling of the personal interview. It also emerged that some content required revision and that the aid was unsuitable for patients with primary progressive MS.CONCLUSIONS: The results of the study further support the value of the aid and also provide important indications for improving it and refining indications for use.",
keywords = "Adult, Clinical Trials as Topic, Female, Humans, Male, Middle Aged, Multiple Sclerosis, Patient Education as Topic, Patients, Physicians, Qualitative Research, Time Factors",
author = "Claudia Borreani and Andrea Giordano and Monica Falautano and Alessandra Lugaresi and Vittorio Martinelli and Franco Granella and Carla Tortorella and Imma Plasmati and Marta Radaelli and Deborah Farina and {Dalla Bella}, Eleonora and Elisabetta Bianchi and Nicola Acquarone and Guido Miccinesi and Alessandra Solari and {SIMS-Trial group} and Christoph Heesen",
note = "{\textcopyright} 2011 John Wiley & Sons Ltd.",
year = "2014",
month = feb,
day = "1",
doi = "10.1111/j.1369-7625.2011.00736.x",
language = "English",
volume = "17",
pages = "36--48",
journal = "HEALTH EXPECT",
issn = "1369-6513",
publisher = "Wiley-Blackwell",
number = "1",

}

RIS

TY - JOUR

T1 - Experience of an information aid for newly diagnosed multiple sclerosis patients: a qualitative study on the SIMS-Trial

AU - Borreani, Claudia

AU - Giordano, Andrea

AU - Falautano, Monica

AU - Lugaresi, Alessandra

AU - Martinelli, Vittorio

AU - Granella, Franco

AU - Tortorella, Carla

AU - Plasmati, Imma

AU - Radaelli, Marta

AU - Farina, Deborah

AU - Dalla Bella, Eleonora

AU - Bianchi, Elisabetta

AU - Acquarone, Nicola

AU - Miccinesi, Guido

AU - Solari, Alessandra

AU - SIMS-Trial group

AU - Heesen, Christoph

N1 - © 2011 John Wiley & Sons Ltd.

PY - 2014/2/1

Y1 - 2014/2/1

N2 - BACKGROUND: The SIMS-Trial (ISRCTN81072971) proved the effectiveness, in terms of patient's knowledge and care satisfaction, of an add-on information aid (personal interview with a physician using a navigable CD and take-home booklet) in 120 newly diagnosed patients with multiple sclerosis (MS) from five Italian centres.OBJECTIVE: To scrutinize the experience of SIMS-Trial participants in order to gain better understanding of the effectiveness of the information aid and its components.DESIGN: We performed (i) nine individual semi-structured interviews with a purposeful sample of SIMS-Trial patients who received the information aid, (ii) focus group meeting (FGM) with the physicians who conducted the personal interview, and (iii) FGM with patients' caring neurologists.RESULTS: Patients' experience with the information aid was positive as it enhanced their understanding of their disease, being viewed as a guided tour of their medical condition. The physicians who conducted the personal interviews were also positive in their overall evaluation but noted an initial difficulty in using the CD. The caring neurologists had limited direct experience of the aid, and their views were confined to utility of the information aid in general. All participants considered the combination of personal interview, CD navigation and take-home booklet essential, but urged a more flexible scheduling of the personal interview. It also emerged that some content required revision and that the aid was unsuitable for patients with primary progressive MS.CONCLUSIONS: The results of the study further support the value of the aid and also provide important indications for improving it and refining indications for use.

AB - BACKGROUND: The SIMS-Trial (ISRCTN81072971) proved the effectiveness, in terms of patient's knowledge and care satisfaction, of an add-on information aid (personal interview with a physician using a navigable CD and take-home booklet) in 120 newly diagnosed patients with multiple sclerosis (MS) from five Italian centres.OBJECTIVE: To scrutinize the experience of SIMS-Trial participants in order to gain better understanding of the effectiveness of the information aid and its components.DESIGN: We performed (i) nine individual semi-structured interviews with a purposeful sample of SIMS-Trial patients who received the information aid, (ii) focus group meeting (FGM) with the physicians who conducted the personal interview, and (iii) FGM with patients' caring neurologists.RESULTS: Patients' experience with the information aid was positive as it enhanced their understanding of their disease, being viewed as a guided tour of their medical condition. The physicians who conducted the personal interviews were also positive in their overall evaluation but noted an initial difficulty in using the CD. The caring neurologists had limited direct experience of the aid, and their views were confined to utility of the information aid in general. All participants considered the combination of personal interview, CD navigation and take-home booklet essential, but urged a more flexible scheduling of the personal interview. It also emerged that some content required revision and that the aid was unsuitable for patients with primary progressive MS.CONCLUSIONS: The results of the study further support the value of the aid and also provide important indications for improving it and refining indications for use.

KW - Adult

KW - Clinical Trials as Topic

KW - Female

KW - Humans

KW - Male

KW - Middle Aged

KW - Multiple Sclerosis

KW - Patient Education as Topic

KW - Patients

KW - Physicians

KW - Qualitative Research

KW - Time Factors

U2 - 10.1111/j.1369-7625.2011.00736.x

DO - 10.1111/j.1369-7625.2011.00736.x

M3 - SCORING: Journal article

C2 - 22040528

VL - 17

SP - 36

EP - 48

JO - HEALTH EXPECT

JF - HEALTH EXPECT

SN - 1369-6513

IS - 1

ER -